We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Spectra Systems Corporation | LSE:SPSY | London | Ordinary Share | COM SHS USD0.01 (UNRES) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 2.29% | 223.00 | 216.00 | 230.00 | 223.00 | 218.00 | 218.00 | 48,356 | 08:42:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Computer Programming Service | 19.63M | 6.15M | 0.1364 | 19.06 | 117.15M |
TIDMSPSY TIDMSPSC
RNS Number : 7780U
Spectra Systems Corporation
23 January 2017
Spectra Systems Corporation
("The Company" or "Spectra Systems")
Appointment of Chief Financial Officer
Spectra Systems, a leading supplier of authentication technology for banknotes, brand authentication and tax stamps, is delighted to announce that, subject to the satisfactory conclusion of due diligence, it has agreed to appoint Brian E McLain C.P.A. (aged 41) as its new Chief Financial Officer.
Brian McLain started his career in 1997 at Arthur Andersen prior to working as a senior accountant at Excelergy Corporation, a software business, located in Lexington, MA from 2000 until 2003. Until late 2006, he then progressed through various roles at International Power, a UK owned power producer located in Marlborough MA, prior to joining SeraCare Life Sciences, Inc, a manufacturer of biological products for the diagnostics and drug discovery markets located in Milford MA. At SeraCare, which was quoted on NASDAQ prior to being bought out in 2012, he progressed from the role of Corporate Controller to Vice President, Finance & Business Solutions. In 2014, he then joined OMNIlife Science Inc., a manufacturer and distributor of orthopaedic devices located in Raynham, MA, in the role of Corporate Controller.
A further announcement will be made upon the conclusion of due diligence by certain of Spectra's customers and the completion of standard regulatory AIM background checks. This due diligence is expected to be completed by no later than February 2017. In the meantime, Doug Anderson, the previous Chief Financial Officer is continuing to assist Spectra as necessary.
Brian McLain joined SeraCare Life Sciences Inc. ("SeraCare") in January 2007, at which point it was already in a bankruptcy process. All creditors were subsequently settled and SeraCare exited the bankruptcy process. There are no other matters which are required to be announced pursuant to paragraph (g) of Schedule 2 to the AIM Rules.
This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.
Dr. Nabil Lawandy, CEO of Spectra Systems, stated: "I am delighted to welcome Brian to Spectra Systems and believe that his extensive financial experience in both private and public businesses as well as his experience in technology driven companies will be of immense value to us."
Enquiries:
Spectra Systems Corporation
Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700
WH Ireland Limited
Chris Fielding (Head of Corporate Finance) Tel: +44 (0) 20 7220 1650
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSEFFWSFWSEFF
(END) Dow Jones Newswires
January 23, 2017 02:00 ET (07:00 GMT)
1 Year Spectra Systems Chart |
1 Month Spectra Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions